Expert narratives in cardiovascular disease and antihyperglycemic therapy

(CEM 237 EN)

Title : Expert narratives in cardiovascular disease and antihyperglycemic therapy

Format : Interactive conference

Time : 1h to 1.5h of Category 1 credits

Beginning : december 2019

Validation and credit : 1h to 1.5h of Category 1 credits to the participants in this activity

Collaboration : This program has received an educational grant and in-kind support from Eli Lilly 

Learning objectives:
Upon completion of this program, participants will be better able to:

  • Discuss the practical application of screening patients with T2DM for CV risk factors
  • Describe how the patient populations in the antihyperglycemic cardiovascular outcome trials differ from one another and the clinical significance of these differences
  • Develop a cardioprotective treatment plan for patients with T2DM and established CVD as well as those with no prior CVD based on that patient's age and CV risk factors

Comité scientifique :

  • Alice Y. Y. Cheng, M.D., FRCPC , Toronto (Ontario)
  • Jeffrey Habert, M.D., CCMF, FCMF , Toronto (Ontario)
  • Johanne Desforges, M.D., Montréal (Québec)
  • James Kim, MB, BCh, Calgary (Alberta) 
  • Lionel Noronha, M.D., CCFP, FCFP, Stirling (Ontario)
  • Jean-François Yale, M.D., CSPQ, FRCPC, Montréal (Québec)

Renseignements : Direction de la Formation professionnelle de la FMOQ. 514 878-1911 ou au 1 800 361-8499, dfp@fmoq.org